Latest News

Nature Biotechnology: Enzymatic DNA synthesis enters new phase

Nuclera is featured in a Nature Biotechnology article!

Our latest news

Nuclera Announces Appointment of Colin Barnes and Kristine Friscino to its Executive Leadership Team

3 min read
Nuclera Announces Appointment of Two New VPs, Charu Maini and Eugene Bragin

4 min read
Nuclera raises $42.5M in first close of Series B for desktop protein printer

3 min read

Want to know more about our mission to change synthetic biology?

Our mission is simple: provide high-quality genes and proteins at your benchtop.